One River Asset Management, LLC Amgen Inc Call Options Transaction History

One River Asset Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $3.47 Million - $4.21 Million	-13,200 Reduced 91.03%	1,300 $406 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $8.98 Million - $10.8 Million	-33,400 Reduced 69.73%	14,500 $4.12 Billion
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $2.38 Million - $2.68 Million	9,300 Added 24.09%	47,900 $13.8 Billion
Q3 2023 Dec 14, 2023	BUY	$218.65 - $271.46 $8.44 Million - $10.5 Million	38,600 New	38,600 $10.4 Billion

3,126

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $138B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of One River Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on One River Asset Management, LLC with notifications on news.